Clinical Trials Logo

Clinical Trial Summary

Non-tuberculous mycobacteriosis (NTM) are infectious diseases caused by mycobacteria that are not part of the Tuberculosis complex. More than 190 species have been identified to date. As an environmental reservoir, it most often affects the lungs, skin and soft tissues, lymph nodes, but it can affect all organs. Varying in virulence depending on the species, most infections do not cause illness. There is currently no coordinated care pathway for this pathology in Alsace. The means necessary to set up such a structure requires knowing the importance of the disease.


Clinical Trial Description

The aim of the study is to determine the incidence of non-tuberculous mycobacterial infections in the ALSACE region, the proportion of cases in which the infection causes illness, and its evolution over time. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06185166
Study type Observational
Source University Hospital, Strasbourg, France
Contact Loïc KASSEGNE, MD
Phone 33 3 69 55 01 88
Email loic.kassegne@chru-strasbourg.fr
Status Recruiting
Phase
Start date December 5, 2022
Completion date June 5, 2024

See also
  Status Clinical Trial Phase
Completed NCT04884308 - Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections Phase 2